2024-11-14 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis Report

**Company Overview:** Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a wide range of medical devices, pharmaceuticals, and nutritional products.

**1. Performance vs. S&P 500:**

* **Cumulative Return:**  ABT: 141.89%, VOO: 179.47%
* **Return Difference:** ABT is trailing VOO by **-37.58%**.
* **Relative Outperformance:** ABT's current performance is in the 9th percentile of its historical performance range compared to VOO.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 36.2% | 23.4% | -2.2% | 1.1 | 99.0 |
| 2016-2018  | 80.0% | 14.7% | 47.7% | 1.1 | 125.5 |
| 2017-2019  | 135.6% | 11.7% | 83.9% | 1.1 | 150.7 |
| 2018-2020  | 95.8% | 31.2% | 48.5% | 0.9 | 189.9 |
| 2019-2021  | 112.3% | 31.2% | 12.3% | 0.8 | 244.1 |
| 2020-2022  | 32.4% | 31.2% | 8.8% | 0.8 | 190.4 |
| 2021-2023  | 6.2% | 30.6% | -28.7% | 0.7 | 190.9 |
| 2022-2024  | -11.9% | 29.6% | -42.4% | 0.7 | 202.0 |

* ABT's performance has generally been in line with the market (beta close to 1). 
* However, in recent years (2021-2024), ABT has shown lower volatility and weaker performance compared to VOO, indicating a lower risk profile but also a lower potential for returns.

**2. Recent Price Movements:**

* **Last Close:** $115.74
* **5-Day Moving Average:** $116.17
* **20-Day Moving Average:** $116.26
* **60-Day Moving Average:** $114.71

**Price Action:** ABT's price is currently trading below both its 5-day and 20-day moving averages, suggesting some short-term weakness. However, the price is above the 60-day moving average, which indicates potential for longer-term upward momentum.

**3. Technical Indicators:**

* **RSI:** 47.58 - This suggests that ABT is in a neutral territory, neither overbought nor oversold.
* **PPO:** -0.08 -  This indicates a slight bearish sentiment, but not a strong signal.
* **Delta_Previous_Relative_Divergence:** -7.98 - This shows a recent short-term downtrend in the stock's performance compared to VOO.
* **Expected Return:** 0.0% - This suggests that over the long term (2 years+), ABT is expected to generate similar returns to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date         | EPS     | Revenue  |
|--------------|--------|---------|
| 2024-10-31   | 0.94    | $10.63 B |
| 2024-07-31   | 0.74    | $10.38 B |
| 2024-05-02   | 0.7     | $9.96 B |
| 2023-11-01   | 0.82    | $10.14 B |
| 2024-10-31   | 0.82    | $10.14 B |

* ABT has consistently delivered solid earnings and revenue growth over the past few quarters. 
* **Most recent earnings (2024-10-31):** The company beat analysts' expectations for both EPS and revenue. 
* **Outlook:** ABT's future growth prospects remain strong, driven by factors such as its diversified product portfolio, a robust pipeline of new products, and a global footprint.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|---------|---------------|
| 2024-09-30  | $10.63B | 55.83%        |
| 2024-06-30  | $10.38B | 55.64%        |
| 2024-03-31   | $9.96B  | 55.21%        |
| 2023-12-31  | $10.24B | 55.51%        |
| 2023-09-30  | $10.14B | 54.60%        |

* ABT has demonstrated consistent revenue growth and strong profitability over the past few quarters.
* The profit margin remains consistently high, indicating efficient operations and effective cost management.

**2) Capital and Profitability:**

| Quarter      | Equity   | ROE |
|--------------|---------|-----|
| 2024-09-30  | $39.80B | 4.14% |
| 2024-06-30  | $39.32B | 3.31% |
| 2024-03-31   | $38.81B | 3.16% |
| 2023-12-31  | $38.60B | 4.13% |
| 2023-09-30  | $37.48B | 3.83% |

* ABT maintains a strong capital position and a healthy ROE, indicating its ability to generate profit from its equity. 

**6. News and Recent Events:**

* **Earnings Release:** Check Shacknews and other financial news outlets for the latest earnings release and subsequent analysis.
* **Analyst Opinions:** Consult sites like Finbold for recent analyst reports and price targets.
* **Recent Market Outlook:** Investigate current market sentiment for ABT and its industry, identifying potential drivers and headwinds for the stock.

**7. Summary:**

Abbott Laboratories (ABT) is a financially strong company with a diversified product portfolio, solid earnings, and a promising future. However, its recent performance has lagged the S&P 500, showing lower volatility and weaker returns. While technical indicators suggest a neutral to slightly bearish sentiment, ABT's fundamentals remain strong, offering a compelling investment opportunity for long-term investors seeking a steady, reliable return with lower risk.

**Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own research and seek professional advice before making any investment decisions. 
